TMDX FY 2025 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

FY 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$605M+37.1% YoY

Gross Profit

$363M59.9% margin

Operating Income

$109M17.9% margin

Net Income

$190M31.4% margin

EPS (Diluted)

$4.87

Cash Flow

Operating Cash Flow

$193M

Free Cash Flow

$134M

Stock-Based Comp.

$37M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$595M

Stockholders' Equity

$473M

Cash & Equivalents

$488M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$605M	$442M	+37.1%
Gross Profit	$363M	$262M	+38.4%
Operating Income	$109M	$37M	+189.6%
Net Income	$190M	$35M	+436.6%